← Eichor
Condition: Anca Vasculitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anca Vasculitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT02257866Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associate
Phase 1 · 1 location(s) · IRIS Research and Development, LLC · NCT06581562A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Phase 1/Phase 2 · 17 location(s) · Nkarta, Inc. · NCT06733935Ocular Manifestations of Granulomatosis With Polyangiitis.
Phase N/A · 1 location(s) · Military Institute od Medicine National Research Institute · NCT07664709Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic A
NA · 45 location(s) · Hospices Civils de Lyon · NCT03290456CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 1/Phase 2 · 1 location(s) · Marcela V. Maus, M.D.,Ph.D. · NCT07388277Rescue of Nephrons With ALE.F02 (RENAL-F02)
Phase 2 · 51 location(s) · Alentis Therapeutics AG · NCT06047171VCRC Tissue Repository
Phase N/A · 8 location(s) · University of Pennsylvania · NCT02967068Rare AutoImmune SElf-management Programme Development
Phase N/A · 1 location(s) · University of the West of England · NCT06642870Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
Phase N/A · 1 location(s) · CHU de Reims · NCT06462768A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07123519(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
Phase N/A · 1 location(s) · Ruijin Hospital · NCT07151521One-Time DNA Study for Vasculitis
Phase N/A · 14 location(s) · University of Pennsylvania · NCT01241305The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
Phase 1 · 1 location(s) · Nanjing University School of Medicine · NCT06285279Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Phase N/A · 6 location(s) · Santé Arménie French-Armenian Research Center · NCT05904301A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Phase 4 · 83 location(s) · Amgen · NCT06072482CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07586267A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06978647Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Phase N/A · 13 location(s) · University of Pennsylvania · NCT00315380Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube
Phase 1 · 1 location(s) · Mayo Clinic · NCT07556484Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04871191Multicenter Cohort Study of AAV in Hunan of China
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT05315141Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Nanjing Bioheng Biotech Co., Ltd. · NCT06775912A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （
Phase 2/Phase 3 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT05979051A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Phase 1 · 1 location(s) · Therorna · NCT07413341Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Va
Phase 2 · 78 location(s) · Alexion Pharmaceuticals, Inc. · NCT07160608A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
EARLY_Phase 1 · 1 location(s) · Nanjing Bioheng Biotech Co., Ltd. · NCT07203404The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangii
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07275190
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.